CLINICAL SIGNIFICANCE OF DETECTION OF EGFR AND KRAS MUTATIONS IN PLASMA/PLEURAL EFFUSION IN PATIENTS WITH ADVANCED NSCLC

被引：0
作者：
Chen, Zhengtang [1 ]
Sun, Jie [1 ]
Ming, Hua [1 ]
Sun, Jianguo [1 ]
Wang, Xinxin [1 ]
Peng, Lina [1 ]
机构：
[1] Third Mil Med Univ, Xinqiao Hosp, Inst Canc, Chongqing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
NSCLC; EGFR/KRAS mutation; tyrosine kinase inhibitor; pyrosequencing;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.06-003
引用
收藏
页码：S781 / S782
页数：2
相关论文
共 50 条
  • [21] Clinical significance of EGFR expression in tumor stroma of NSCLC
    Pang, Qiuhua
    Xing, Ying
    Li, Jing
    Fu, Xianwen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (09): : 17475 - 17486
  • [22] Enhanced detection of actionable mutations in NSCLC through pleural effusion cell-free DNA sequencing: A prospective study
    Wang, Hsin-Yi
    Liao, Wei-Yu
    Ho, Chao-Chi
    Wu, Shang-Gin
    Yang, Ching-Yao
    Hsu, Chia-Lin
    Lin, Yen-Ting
    Yang, James Chih-Hsin
    Shih, Jin-Yuan
    EUROPEAN JOURNAL OF CANCER, 2025, 217
  • [23] Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencing
    Evgeny A. Moskalev
    Robert Stöhr
    Ralf Rieker
    Simone Hebele
    Florian Fuchs
    Horia Sirbu
    Sergey E. Mastitsky
    Carsten Boltze
    Helmut König
    Abbas Agaimy
    Arndt Hartmann
    Florian Haller
    Virchows Archiv, 2013, 462 : 409 - 419
  • [24] Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencing
    Moskalev, Evgeny A.
    Stoehr, Robert
    Rieker, Ralf
    Hebele, Simone
    Fuchs, Florian
    Sirbu, Horia
    Mastitsky, Sergey E.
    Boltze, Carsten
    Koenig, Helmut
    Agaimy, Abbas
    Hartmann, Arndt
    Haller, Florian
    VIRCHOWS ARCHIV, 2013, 462 (04) : 409 - 419
  • [25] Urinary circulating DNA detection for dynamic tracking of EGFR mutations for NSCLC patients treated with EGFR-TKIs
    S. Chen
    J. Zhao
    L. Cui
    Y. Liu
    Clinical and Translational Oncology, 2017, 19 : 332 - 340
  • [26] Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients
    Hackner, Klaus
    Buder, Anna
    Hochmair, Maximilian J.
    Strieder, Matthaeus
    Grech, Christina
    Fabikan, Hannah
    Burghuber, Otto C.
    Errhalt, Peter
    Filipits, Martin
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021, 15
  • [27] Rare and Common EGFR Mutations in Patients with Advanced NSCLC Treated with EGFR-TKIs: A Registry-Based Study
    Pesek, Milos
    Kolek, Vitezslav
    Skrickova, Jana
    Cernovska, Marketa
    Koubkova, Leona
    Roubec, Jaromir
    Salajka, Frantisek
    Zemanova, Milada
    Krejci, Jana
    Hejduk, Karel
    Ryska, Ales
    Minarik, Marek
    Fiala, Ondrej
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S318 - S318
  • [28] Urinary circulating DNA detection for dynamic tracking of EGFR mutations for NSCLC patients treated with EGFR-TKIs
    Chen, S.
    Zhao, J.
    Cui, L.
    Liu, Y.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (03) : 332 - 340
  • [29] Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision
    Sousa, A. C.
    Silveira, C.
    Janeiro, A.
    Malveiro, S.
    Oliveira, A. R.
    Felizardo, M.
    Nogueira, F.
    Teixeira, E.
    Martins, J.
    Carmo-Fonseca, M.
    LUNG CANCER, 2020, 139 : 35 - 40
  • [30] Real-world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi-center study
    Qin, Yi
    Long, Yaling
    Tang, Yuan
    Tian, Yuke
    Li, Juan
    Duan, Ping
    Luo, Jieyan
    Yu, Min
    Li, Yanying
    Zhou, Xiaojuan
    Wang, Ke
    Gong, Youling
    Peng, Feng
    Zhu, Jiang
    Liu, Yongmei
    Zhou, Lin
    Lu, You
    Huang, Meijuan
    CANCER SCIENCE, 2023, 114 (06) : 2552 - 2559
12345